These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18374552)

  • 1. Increasing sodium pantoprazole photostability by microencapsulation: effect of the polymer and the preparation technique.
    Raffin RP; Colomé LM; Schapoval EE; Pohlmann AR; Guterres SS
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1014-8. PubMed ID: 18374552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in photostability of pantoprazole sodium by microencapsulation.
    Dhurke R; Kushwaha I; Desai BG
    PDA J Pharm Sci Technol; 2013; 67(1):43-52. PubMed ID: 23385563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of HPMC and Eudragit S100 blended microparticles containing sodium pantoprazole.
    Raffin RP; Colomé LM; Haas SE; Jornada DS; Pohlmann AR; Guterres SS
    Pharmazie; 2007 May; 62(5):361-4. PubMed ID: 17557744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: effect of the scale of production and process validation.
    Raffin RP; Jornada DS; Ré MI; Pohlmann AR; Guterres SS
    Int J Pharm; 2006 Oct; 324(1):10-8. PubMed ID: 16889914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric controlled-release pantoprazole-loaded microparticles prepared by using Eudragit S100 and poly(epsilon-caprolactone) blend.
    Raffin RP; Colomé LM; Guterres SS; Pohlmann AR
    Pharm Dev Technol; 2007; 12(5):463-71. PubMed ID: 17963146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro evaluation of pantoprazole-loaded microspheres.
    Comoglu T; Gonul N; Dogan A; Basci N
    Drug Deliv; 2008 Jun; 15(5):295-302. PubMed ID: 18763160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
    Chen MM; Wang CR; Jin Y
    Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural elucidation of rabeprazole sodium photodegradation products.
    Garcia CV; Nudelman NS; Steppe M; Schapoval EE
    J Pharm Biomed Anal; 2008 Jan; 46(1):88-93. PubMed ID: 17945453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
    Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
    J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of burst release from pH-responsive polymeric microparticles.
    Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
    J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles.
    Raffin RP; Colomé LM; Pohlmann AR; Guterres SS
    Eur J Pharm Biopharm; 2006 Jun; 63(2):198-204. PubMed ID: 16531029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mupirocin calcium microencapsulation via spray drying: feed solvent influence on microparticle properties, stability and antimicrobial activity.
    Dürrigl M; Kregar ML; Hafner A; Klarić MŠ; Filipović-Grčić J
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1402-14. PubMed ID: 21702740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pantoprazole formulations in different dissolution apparatus using biorelevant medium.
    de Campos DR; Klein S; Zoller T; Vieria NR; Barros FA; Meurer EC; Coelho EC; Marchioretto MA; Pedrazzoli J
    Arzneimittelforschung; 2010; 60(1):42-7. PubMed ID: 20184226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY; Körber M; López Esguerra V; Bodmeier R
    J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agglomerates containing pantoprazole microparticles: modulating the drug release.
    Raffin RP; Colombo P; Sonvico F; Rossi A; Jornada DS; Pohlmann AR; Guterres SS
    AAPS PharmSciTech; 2009; 10(2):335-45. PubMed ID: 19319687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis.
    Banerjee R; Reddy DN; Guda NM; Kalpala R; Mahurkar S; Darisetty S; Rao GV
    J Gastroenterol Hepatol; 2010 Jan; 25(1):43-7. PubMed ID: 19874444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole.
    Melkoumov A; Soukrati A; Elkin I; Forest JM; Hildgen P; Leclair G
    Am J Health Syst Pharm; 2011 Nov; 68(21):2069-74. PubMed ID: 22011986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.